Gelteq (GELS) Cash from Investing Activities (2023 - 2025)
Gelteq (GELS) posted quarterly Cash from Investing Activities of -$42808.7 for Q4 2025, up 80.06% year-over-year from -$23775.2 in Q4 2024, and up 80.06% quarter-over-quarter from -$214642.9 in Q4 2024.
Gelteq (GELS) Cash from Investing Activities (2023 - 2025) Analysis & Trends
Gelteq's Cash from Investing Activities history runs 3 years deep, the most recent figure standing at -$42808.7 for Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Gelteq | 5.90 Mn | 5.63 Mn | - | -42,808.72 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -42,808.72 |
| Dec 31, 2025 | -42,808.72 |
| Dec 31, 2024 | -214,642.94 |
| Dec 31, 2024 | -214,642.94 |
| Dec 31, 2023 | -52,053.85 |
| Dec 31, 2023 | -52,053.85 |